BeyondSpring Inc. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-25: Form 10-K; Period of report 2025-12-31; Description FORM 10-K; Document bysi20251231_10k.htm.
- 2025-03-27: Form 10-K; Period of report 2024-12-31; Description FORM 10-K; Document bysi20241231_10k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-25 | 10-K | 2025-12-31 | FORM 10-K | bysi20251231_10k.htm |
| 2025-03-27 | 10-K | 2024-12-31 | FORM 10-K | bysi20241231_10k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |